Guangzhou Xiling Biotechnology Co., Ltd.
Guangzhou Xiling Biotechnology Co., Ltd.
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Tolerability Evaluation of CEL001 Injection in Advanced Solid Tumors | Advanced Solid Tumors (Phase 1) | Recruiting | Phase 1 | 2025-12-02 | NCT07259889 |